وقدم التمويل لهذا المشروع من قبل معهد كاليفورنيا للطب التجديدي.

1. Lentivirus production, harvest, and freezing
<ol>
	<li>Consult your institutional safety official before beginning this protocol, and follow their recommended safety guidelines.</li>
	<li>Day 1. Start with healthy, rapidly growing 293T cells to produce virus. Plate the cells at 5 x 106 
	cells per 10 cm plate. Use antibiotic-free 293T medium (high-glucose DMEM with 10% FBS and 4 mM L-glutamine) for virus production.</li>
	<li>Day 2. In the late afternoon, transfect 293T cells as follows (numbers given are for one 10 cm plate). 
	Let all reagents warm up to room temperature. Pipette 375 &mu;l OptiMEM into a microcentrifuge tube, then add 25 &mu;l 
	Fugene HD. Do not allow undiluted Fugene to contact the surface of the tube.</li>
	<li>In a microcentrifuge tube, mix:
		<ul>
			<li>5 &mu;g transfer plasmid (Slc7a1, target vector, or fluorescent control vector)</li>
			<li>3.75 &mu;g packaging plasmid (pCMV-dR8.91 or psPax2)</li>
			<li>1.25 &mu;g envelope plasmid (pMD2.G for pantropic, pHCMV-EcoEnv for ecotropic)</li>
			<li>serum-free OptiMEM to 100 &mu;l</li>
		</ul>
	</li>
	<li>Combine the two tubes and incubate the mixture 20-30 minutes at room temperature.</li>
	<li>Change the medium on the 293T cells to 10 ml fresh antibiotic-free 293T medium. Add the Fugene/plasmid mix 
	drop-wise to the plate and incubate overnight at 37&deg;C, 5% CO2.</li>
	<li>Day 3. Change medium on the 293T cells to 10 ml fresh antibiotic-free 293T medium. Be gentle, 
	because 293T cells adhere only loosely and can slough off by media pipetted too forcefully onto the 
	monolayer. Incubate for two days in a humidified incubator for virus production.</li>
	<li>Day 5. Harvest virus and filter with a 0.45 mm low protein binding filter. Use immediately or dispense 
	into single-use aliquots and freeze at -80&deg;C. Frozen pantropic and ecotropic virus should be re-titered after it has 
	been stored for six months and one month, respectively.</li>
	<li>Titer the virus as follows, using cells that are relatively amenable to transduction. Transduce cells with fluorescent control virus overnight using serial dilutions (e.g. 1:10, 1:100, 1:1000) in fresh medium with 6 &mu;g/ml PB. Change to fresh medium the next day. Allow the cells two days after transduction to begin expressing the fluorescent protein, then determine the fraction of transduced cells by FACS. Calculate the titer in transforming units (TU) per ml, based on dilutions that yield &lt; 15% transduction to minimize multiple transduction events. 
	<img src="/files/ftp_upload/2822/2822eq1.jpg" alt="Equation 1" />
	</li>
</ol>
2. Transduction of human target cells with murine retrovirus receptor Slc7a1
<ol>
	<li>Select a multiplicity of infection (MOI) = 2 to ensure that most cells will be transduced. For target cells that are resistant to transduction such as HDFs, a higher MOI will be required; we dilute the viral supernatant only 1:2 to achieve transduction of a majority of the cells.</li>
	<li>Transduce target cells overnight with viral supernatant diluted in fresh culture medium with 6 &mu;g/ml PB, which increases transduction by enhancing electrostatic interaction between the virus and target cell.1 Ideally one should use a minimal volume of virus, such as 1 ml for a 35 mm plate, because diffusion is a limiting factor in transduction efficiency. </li>
	<li>Culture cells for at least 48 hours after removing virus before transducing them with ecotropic virus, in order to ensure sufficient expression of the Slc7a1 receptor.</li>
	<li>(Optional) It is possible to use blasticidin to select for stably transduced cells expressing Slc7a1, if desired. A blasticidin kill curve should be generated in advance to determine the lowest effective concentration, generally between 2 &#x2013; 10 &mu;g/ml, that kills all untransduced target cells in 7 days. About 2 days after removing the Slc7a1 virus, switch the transduced cells to medium containing blasticidin. Culture the cells in blasticidin-containing medium for 7 days, at which point all remaining cells will stably express the retrovirus receptor at which point they can be transduced with ecotropic virus as well as banked for future use as a stable Slc7a1-expressing line.</li>
</ol>
3. Polymer complex titration to determine toxicity
<ol>
	<li>Day 1. Plate cells at 5000 cells/well in a 96-well plate, allowing at least triplicate wells for each experimental group. Include untransduced cells in complete medium to provide a baseline value for healthy cells, as well as samples consisting of cells in serum-free medium to induce growth arrest as a control. In parallel, plate cells in an appropriate format (such as a 24-well plate) for microscopic or FACS-based analysis of transduction efficiency in each experimental condition.</li>
	<li>Day 2. Transduce cells in plates set up for both the MTT and FACS analyses with virus encoding GFP, at an MOI of 0.5 to transduce ~40% of target cells. Test varied concentrations of CS/PB (e.g. 50, 100, 200, 400, 600, and 800 mg/ml of each component), as well as 6 &mu;g/ml PB, to determine optimal amounts. Generate polymer complexes as described in Part 4, below.</li>
	<li>Day 3. Remove virus-containing medium and replace with fresh medium. Return the plates to a humidified incubator.</li>
	<li>Day 5. Analyze FACS plate to determine the transduction efficiency with each polymer concentration. </li>
	<li>Day 6. Remove the medium from all wells of the MTT plate and replace with 100 &mu;l MTT solution (1 mg/ml MTT in complete medium). Culture for three hours in a humidified incubator to allow MTT to be reduced in the mitochondria of metabolically active cells.</li>
	<li>Remove MTT solution and replace with 200 ml MTT solvent (0.1 N HCl, 0.1% Igepal CA-630 in isopropanol). </li>
	<li>Incubate for two hours at room temperature or until all of the purple MTT formazan precipitate is dissolved. Read the absorbance on a microplate reader at 570 nm, subtracting the background reading at 690 nm. </li>
	<li>Select the optimal polymer concentration that produces maximum enhancement of transduction, as determined by FACS, with minimal effect on metabolic activity, as determined by MTT. For HDFs, we selected 100 &mu;g/ml CS/PB based on the data shown in the Representative Results, below.</li>
</ol>
4. Ecotropic transduction with polymer complexation
<ol>
	<li>Prepare sterile-filtered stock solutions of PB and chondroitin sulfate at 20 mg/ml in water. Aliquot and store at -20&deg;C.</li>
	<li>Pipette viral supernatant into a microcentrifuge tube and dilute to the desired final concentration (e.g. MOI of 2) with fresh culture medium. Add equal volumes of PB and chondroitin sulfate (concentrations determined in step 3 above) in succession, flicking the tube to mix after each addition. The viral mixture will immediately become cloudy as precipitates form. Incubate the viral mixture at room temperature for 5 minutes to allow complex formation.</li>
	<li>Remove media from the receptor-expressing target cells, replace with the viral mix, and incubate overnight at 37&deg;C, 5% CO2. After removing the viral mix, wash the surface of the cells twice with PBS to aid in removing viral complexes. Complete removal is not necessary; we have observed no adverse effects on cell health from residual polymer complexes.</li>
</ol>
5. Verifying specificity of ecotropic transduction
<ol>
	<li>When producing ecotropic virus for the first time, it is prudent from a safety perspective to verify that the virus is unable to transduce unmodified human cells. Transduce human cells with ecotropic lentivirus at relatively high concentration (only a 1 to 2-fold dilution of viral supernatant in fresh medium) overnight with 6 &mu;g/ml PB or optimized CS/PB concentration. </li>
	<li>Remove virus-containing medium and replace with fresh medium. After incubating cells for 2 days, validate transgene expression by FACS using fluorescent vectors and/or by RT-PCR with transgene-specific primers.</li>
</ol>
6. Representative results:
Fig. 1A shows the lentivirus production process, and Fig. 1B shows transduction of human cells with ecotropic lentivirus, including pre-transduction with murine retrovirus receptor Slc7a1. For titering virus, we use a human rhabdomyosarcoma cell line stably transduced with Slc7a1 (Slc-hRMS). When using fluorescent control vectors to monitor transduction efficiency, we routinely achieve > 90% transduction efficiency of Slc-hRMS with ecotropic virus, as shown in Fig. 2A and 2B. Transduction rates of HDFs are generally lower because the cells have not been blasticidin-selected for receptor expression (Fig. 2C). Titers of ecotropic lentivirus are generally 10-20% of VSV-pseudotyped virus when measured on Slc-hRMS (Fig. 2D).
One freeze-thaw cycle reduces titer of ecotropic virus by 16 - 3%, equal to titer loss during a single freeze-thaw cycle of VSV-pseudotyped virus (p > 0.05). Contrary to previous reports,2 we observe no positive effect on virus titer from flash freezing in dry ice. Rather, we achieve higher post-thaw titers of either pseudotype by simply placing tubes of virus into a -80&deg;C freezer (data not shown). 
The MTT viability assay allows sensitive detection of growth arrest in target cells. Transduction with virus plus concentrations of CS/PB up to 800 &mu;g/ml has no effect on HDF metabolism (Fig. 3A). Exposure to CS/PB without virus also has no toxic effect on cells (data not shown). FACS analysis of HDFs transduced with virus plus various concentrations of CS/PB shows enhancement of transduction compared to PB alone (Fig. 3B). The maximum enhancement occurs at 100 &mu;g/ml CS/PB (Fig. 3C), several-fold lower than previously reported values.3 Thus, it is important to optimize conditions for any given target cell type.
Complexation with CS/PB enhances the observed titer roughly 3-fold in Slc-hRMS (Fig. 4A, p &lt; 0.01). In practice, this yields a greater effect on transduction efficiency at low virus concentrations than at higher concentrations (Fig. 4B), which is most likely due to multiply transduced cells and receptor saturation at higher virus concentrations.
Transduction with ecotropic virus is specific for cells expressing murine retrovirus receptor. When transducing unmodified human cells with ecotropic virus, we have not observed fluorescence greater than the untransduced background whether using PB or CS/PB, as shown in Fig. 5A. Microscopically, HDFs show no transduction in the absence of receptor (Fig. 5B) while pre-transduction with receptor results in fluorescent cells (Fig. 5C).
<img src="/files/ftp_upload/2822/2822fig1.jpg" alt="Figure 1" /> 
Figure 1. Schematic view of (A) the virus production process and (B) transduction of human cells with murine retrovirus receptor followed by ecotropic lentivirus.
<img src="/files/ftp_upload/2822/2822fig2.jpg" alt="Figure 2" /> 
Figure 2. High-efficiency transduction of human cells with ecotropic lentivirus encoding GFP. Cells were pre-transduced with murine retrovirus receptor Slc7a1. (A) Human rhabdomyosarcoma cell line blasticidin-selected for Slc7a1 (Slc-hRMS), transduced (blue) or untransduced (pink) with GFP. (B) Fluorescent micrograph of ecotropic-transduced Slc-hRMS (4X). (C) HDFs transduced (blue) and untransduced (pink) with ecotropic GFP lentivirus; cells were transduced with Slc7a1 two days prior to ecotropic transduction. (D) Titer of VSV-G pseudotyped and ecotropic lentivirus, measured on Slc-hRMS.
<img src="/files/ftp_upload/2822/2822fig3.jpg" alt="Figure 3" /> 
Figure 3. Optimizing chondroitin sulfate/polybrene (CS/PB) concentrations in human dermal fibroblasts. (A) Viability of HDFs measured by MTT assay after transduction in the presence of PB only or with varied concentrations of CS/PB. (B) Enhancement of transduction efficiency in HDFs by different concentrations of CS/PB, measured by FACS. (C) Quantification of transduction enhancement, showing that maximum transduction occurs at 100 &mu;g/ml CS/PB.
<img src="/files/ftp_upload/2822/2822fig4.jpg" alt="Figure 4" /> 
Figure 4. Effect of 400 &mu;g/ml CS/PB on transduction of Slc-hRMS with ecotropic lentivirus. (A) Titer enhancement, and (B) fold change in transduction rate compared to 6 &mu;g/ml polybrene alone.
<img src="/files/ftp_upload/2822/2822fig5.jpg" alt="Figure 5" /> 
Figure 5. Lack of ecotropic transduction of HDFs in the absence of murine retrovirus receptor Slc7a1. (A) FACS plot of BJ human fibroblasts, untransduced (pink) or transduced (blue) with ecotropic GFP lentivirus in both cases in the absence of receptor Slc7a1. BJ human fibroblasts transduced with ecotropic GFP lentivirus, without (B) and with (C) pre-transduction with receptor Slc7a1 (4X).

<ol>
	<li>Davis, H. E., Rosinski, M., Morgan, J. R., Yarmush, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Charged+polymers+modulate+retrovirus+transduction+via+membrane+charge+neutralization+and+virus+aggregation.">Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation.</a> Biophys J. 86, 1234-1242 (2004).</li><li>Marino, M. P., Luce, M. J., Reiser, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Small-+to+large-scale+production+of+lentivirus+vectors.">Small- to large-scale production of lentivirus vectors.</a> Methods Mol Biol. 229, 43-55 (2003).</li><li>Landazuri, N., LeDoux, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Complexation+of+retroviruses+with+charged+polymers+enhances+gene+transfer+by+increasing+the+rate+that+viruses+are+delivered+to+cells.">Complexation of retroviruses with charged polymers enhances gene transfer by increasing the rate that viruses are delivered to cells.</a> J Gene Med. 6, 1304-1319 (2004).</li><li>Ohnuki, M., Takahashi, K., Yamanaka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+and+characterization+of+human+induced+pluripotent+stem+cells.">Generation and characterization of human induced pluripotent stem cells.</a> Curr Protoc Stem Cell Biol. 4, 4A.2-4A.2 (2009).</li><li>Hotta, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=EOS+lentiviral+vector+selection+system+for+human+induced+pluripotent+stem+cells.">EOS lentiviral vector selection system for human induced pluripotent stem cells.</a> Nat Protoc. 4, 1828-1844 (2009).</li><li>Reiser, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transduction+of+nondividing+cells+using+pseudotyped+defective+high-titer+HIV+type+1+particles.">Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.</a> Proc Natl Acad Sci U S A. 93, 15266-15271 (1996).</li><li>Cullen, B. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Journey+to+the+center+of+the+cell.">Journey to the center of the cell.</a> Cell. 105, 697-700 (2001).</li><li>Cronin, J., Zhang, X. Y., Reiser, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Altering+the+tropism+of+lentiviral+vectors+through+pseudotyping.">Altering the tropism of lentiviral vectors through pseudotyping.</a> Curr Gene Ther. 5, 387-398 (2005).</li><li>Schambach, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lentiviral+vectors+pseudotyped+with+murine+ecotropic+envelope:+increased+biosafety+and+convenience+in+preclinical+research.">Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.</a> Exp Hematol. 34, 588-592 (2006).</li><li>Koch, P., Siemen, H., Biegler, A., Itskovitz-Eldor, J., Brustle, O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transduction+of+human+embryonic+stem+cells+by+ecotropic+retroviral+vectors.">Transduction of human embryonic stem cells by ecotropic retroviral vectors.</a> Nucleic Acids Res. 34, e120-e120 (2006).</li><li>Yoshimoto, T., Yoshimoto, E., Meruelo, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+cloning+and+characterization+of+a+novel+human+gene+homologous+to+the+murine+ecotropic+retroviral+receptor.">Molecular cloning and characterization of a novel human gene homologous to the murine ecotropic retroviral receptor.</a> Virology. 185, 10-17 (1991).</li><li>Cepko, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Large-scale+preparation+and+concentration+of+retrovirus+stocks.">Large-scale preparation and concentration of retrovirus stocks.</a> Curr Protoc Mol Biol. Chapter 9, Unit 9.12-Unit 9.12 (2001).</li><li>Doux, J. M. L. e., Landazuri, N., Yarmush, M. L., Morgan, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Complexation+of+retrovirus+with+cationic+and+anionic+polymers+increases+the+efficiency+of+gene+transfer.">Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer.</a> Hum Gene Ther. 12, 1611-1621 (2001).</li><li>Zufferey, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Self-inactivating+lentivirus+vector+for+safe+and+efficient+in+vivo+gene+delivery.">Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.</a> J Virol. 72, 9873-9880 (1998).</li></ol>

الإعلان عن أي تضارب في المصالح.

ودرس المؤتلف gammaretrovirus ecotropic استنادا فيروس ابيضاض الدم الفأري مولوني (MLV) ومستقبلات mSlc7a1 لها جيدا وعلى نطاق واسع ، بعد أن استخدمت لأكثر من 20 عاما لتوصيل الجينات المحورة إلى خلايا الفئران. كما تم استخدام أكثر gammaretrovirus Ecotropic مؤخرا لتقديم المسرطنة إلى الخلايا البشرية ؛ في سياق إعادة برمجة الخلايا ، واستخدام mSlc7a1 لتجنب توليد فيروس amphotropic بايواء المسرطنة الإنسان راسخة 4،5 ومع ذلك ، الفيروسة البطيئة يوفر مزايا هامة على gammaretrovirus transducing السكان في خلية صهر (6) ، بما في ذلك الخلايا الأولية التي غالبا ما تكون الأهداف المرغوب فيه لإعادة البرمجة ، وذلك لأن lentiviral قبل الاندماج المعقدة تسمح للخلايا تنبيغ عدم تقسيم 7 وقد تم إنتاج Lentiviruses مع العشرات من pseudotypes مختلفة ، بما في ذلك MLV ، في محاولة لتغيير tropism الفيروس ، والسمية ، وغيرها من الممتلكات. استخدمت 8 الفيروسة البطيئة ecotropic MLV - pseudotyped لتنبيغ خلايا فأر ، 9 ولكن نادرا ما كانت تستخدم على الخلايا البشرية 10 لذلك نحن نقترح استخدام MLV - pseudotyped الفيروسة البطيئة ecotropic كوسيلة آمنة وفعالة من حيث التكلفة وعالية الكفاءة لتقديم المسرطنة المعروفة أو المشتبه بهم ، بما في ذلك عوامل إعادة برمجة الخلايا ، والخلايا البشرية. فمن الأهمية بمكان أن نلاحظ أن هذا البروتوكول لا تقضي تماما على الحاجة إلى إنتاج واستخدام الفيروسة البطيئة شمولي التوجه ، بل يفصل بين هذا البروتوكول الجين الورمي (ق) من الفيروس شمولي التوجه ، وعزل باحثون من امكاناتها الذاتية التلقيح مع السرطان المرتبطة الفيروسات. وأعرب بتواجد مطلق في mSlc7a1 البروتين وhSlc7a1 لها نديد الإنسان نقل الأحماض الأمينية مع عدم وجود tumorigenicity معروفة أو القدرة على منح ميزة انتقائية على نمو خلايا المتلقي ، 11 mSlc7a1 صنع منخفضة المخاطر نسبيا لإدراجها في amphotropic الفيروس. هذه الخطوة قد تكون مفيدة بشكل خاص وأضاف في المختبرات تفتقر إلى مرافق مخصصة أو الفيروس زراعة الأنسجة من مستوى السلامة الحيوية المطلوبة. في بعض الحالات قد يكون من الممكن أن تقضي تماما على استخدام فيروس شمولي التوجه من قبل وtransfecting Slc7a1 البلازميد مباشرة إلى الخلايا المستهدفة ، إلا أن العديد من الخلايا التي من شأنها أن تكون مفيدة لأهداف هذه التقنية أيضا لصهر ترنسفكأيشن. كبديل ، والقدرة على عزل الخلايا Slc7a1 - transduced عن طريق الانتقاء blasticidin الوسائل التي يمكن استخدامها VSV - G الفيروسة البطيئة pseudotyped مرة واحدة لإنشاء مخزون من خلايا مستقبلات معربا عن بعد والتي يمكن استخدامها بشكل روتيني لفيروس ecotropic تنبيغ هذه الخلايا بالنسبة لكثير التجارب. وينبغي أن تتبع دائما المبادئ التوجيهية الباحثين سلامتهم المؤسسية للعمل مع أي الفيروسة البطيئة ، بغض النظر عن tropism والخمسين. التتر من فيروس ecotropic يتحقق مع هذا البروتوكول هي أقل نسبيا من VSV - pseudotyped الفيروس ، عادة 10-20 ٪ من عيار الفيروس شمولي التوجه ، بالاتفاق مع الدراسات السابقة. قيست 9 هذه التتر في الخلايا البشرية transduced ستابلي مع Slc7a1 ، وبالتالي فإن انخفاض وقد لاحظ لفيروس عيار ecotropic أن يعزى ذلك جزئيا إلى التعبير متنوعة من الجين في مستقبلات الخلايا المستهدفة. ومع ذلك ، فإن التتر الفيروسية التي تحققت في بروتوكول لدينا هي أكثر من كافية بالنسبة لمعظم التطبيقات ، وتؤدي إلى تنبيغ غالبية الخلايا ، في بعض الحالات&gt; 90 ٪ من الخلايا. ويشيع استخدام التقنيات المعتمدة على الطرد المركزي لتركيز الجسيمات الفيروسية. ويمكن استخدام ومع ذلك ، تتطلب عدة ساعات الطرد المركزي ، ويولد الهباء المعدية ، ويمكن أن يتسبب في خسائر كبيرة من الجزيئات الفيروسية (12). وكبديل ، مع complexation CS / PB لتعزيز تنبيغ دون تغيير tropism الفيروسية. 3 هذا الأسلوب السريع (5 دقائق ) وغير مكلفة (0.03 دولار للفيروس مل 10) ، في حين أن ثلاثة أمثالها تقريبا عيار ملاحظتها. وهناك حاجة إلى معدات خاصة أو الكواشف الملكية ، لاحظنا والحد الأدنى من السمية الحادة بعد التعرض للHDFs إلى CS / PB ، بالاتفاق مع الأعمال السابقة في خطوط الخلايا الأخرى. 13 عيب واحد المحتملة لهذا البروتوكول هو أن بعض مرئية المجهر مجمعات البوليمر التمسك الخلايا لعدة أيام في الثقافة. لا يمكننا استبعاد احتمال ان هذه المجمعات ، في حين لا علنا ​​السامة للخلايا ، قد يكون لها آثار أكثر مكرا على العمليات الخلوية. هنا قد وصفنا منهجية لبأمان وكفاءة الخلايا البشرية transducing مع عوامل أنكجنيك. هذا النهج ينبغي أن تكون ذات فائدة كبيرة للباحثين الذين يدرسون الجينات المسرطنة وبيولوجيا الخلايا الجذعية بما في ذلك خلايا الجذع.

<table border="1" style=";text-align:right;direction:rtl"><tbody><tr><th> اسم كاشف </th><th> شركة </th><th> فهرس العدد </th><th> تعليقات </th></tr><tr><td> pLenti6/UbC/mSlc7a1 </td><td> Addgene </td><td> 17224 </td><td> فأري MLV مستقبلات </td></tr><tr><td> pMD2.G </td><td> Addgene </td><td> 12259 </td><td> VSV - G مغلف </td></tr><tr><td> pCMV - dR8.91 </td><td> دال Trono مختبر 14 </td><td></td><td> التغليف البلازميد (ما يعادل psPax2 البلازميد هو متاح من Addgene ، القط. رقم 12260) </td></tr><tr><td> pHCMV - EcoEnv </td><td> Addgene </td><td> 15802 </td><td> Ecotropic مغلف </td></tr><tr><td> FUGW </td><td> Addgene </td><td> 14883 </td><td> GFP السيطرة البلازميد </td></tr><tr><td> OptiMEM </td><td> Invitrogen </td><td> 31985 </td><td></td></tr><tr><td> Fugene HD </td><td> روش </td><td> 04 709 705 001 </td><td></td></tr><tr><td> Hexadimethrine بروميد (Polybrene) </td><td> سيغما الدريخ </td><td> H9268 </td><td></td></tr><tr><td> شوندروتن كبريتات الصوديوم من غضروف سمك القرش </td><td> سيغما الدريخ </td><td> C4384 </td><td></td></tr><tr><td> Blasticidin S </td><td> الصياد </td><td> BP 2647100 </td><td></td></tr><tr><td> Methylthiazolyldiphenyl - tetrazolium بروميد (MTT) </td><td> سيغما الدريخ </td><td> M2128 </td><td></td></tr><tr><td> Igepal CA - 630 </td><td> سيغما الدريخ </td><td> I3021 </td><td></td></tr></tbody></table>

transduction of human cells with polymer-complexed ecotropic lentivirus for enhanced biosafety

الجذعية وبيولوجيا الخلايا السرطانية دراسات غالبا ما تتطلب تنبيغ الفيروسية من الخلايا البشرية والجينات المسرطنة المعروفة أو المشتبه بهم ، ورفع القضايا الرئيسية لسلامة العاملين في المختبرات. lentiviruses شمولي التوجه ، مثل pseudotype VSV - G شيوعا ، هي أداة قيمة لدراسة وظائف الجينات لأنها يمكن أن تنبيغ أنواع الخلايا عديدة ، بما في ذلك الخلايا غير الانقسام. ومع ذلك ، قد ترغب في تجنب الباحثين الإنتاج والطرد من الفيروسات المسرطنة ترميز شمولي التوجه نتيجة لارتفاع مستوى متطلبات السلامة الأحيائية المناولة وقضايا السلامة. ومن المعروف المسرطنة قوية عدة ، بما في ذلك C - Myc وSV40 المستضد T كبيرة ، لتعزيز إنتاج يسببها الخلايا الجذعية المحفزة (iPSC). كل أخرى معروفة iPSC الذي يحفز التغيرات الجينية (OCT4 ، SOX2 ، KLF4 ، NANOG ، LIN28 ، وفقدان وظيفة البروتين p53) وأيضا وصلات إلى السرطان ، مما يجعلها ذات الاهتمام سلامة عالية نسبيا أيضا. في حين أن هذه الفيروسات المرتبطة بالسرطان مفيدة في دراسة إعادة برمجة الخلايا وتعدد القدرات ، لا بد من استخدامها بأمان. لمعالجة هذه القضايا المتعلقة بالسلامة الأحيائية ، ونحن يبرهن على وجود طريقة لتنبيغ الخلايا البشرية ecotropic الفيروسة البطيئة ، مع التركيز على خفض تكلفة إضافية والمناولة المريحة. أنتجنا الفيروسة البطيئة ecotropic مع عيار مرتفع بما فيه الكفاية لتنبيغ أكبر من 90 ٪ من الخلايا المستقبلة للتعبير عن الإنسان يتعرض للفيروس ، والتحقق من فعالية هذا النهج. ويتركز أغلب الأحيان بواسطة تنبيذ فائق الفيروسة البطيئة ، ولكن هذه العملية تستغرق عدة ساعات ويمكن ان تنتج الهباء المعدية للباحثين الطب الحيوي الإنسان. كما يمكن أن يكون بديلا ، والجسيمات الفيروسية بأمان أكبر الرسوبية على الخلايا complexation مع كبريتات شوندروتن وpolybrene (CS / PB). هذا الأسلوب يزيد من عيار الفيروسية وظيفية تصل إلى أضعاف 3 في خلايا الفئران ستابلي التعبير عن مستقبلات الفيروس الارتجاعي ، مع تذكر الوقت المحتسب بدل الضائع والتكاليف. ومما يعزز من الحد الأقصى تنبيغ الخلايا الليفية الجلد البشري (HDFs) باستخدام CS / PB تركيزات ما يقرب من 4 أضعاف أقل من القيمة المثلى ذكرت سابقا لخطوط الخلايا السرطانية ، مما يوحي معاير ينبغي أن تركيز البوليمر لنوع من الخلايا المستهدفة من الفائدة. وصفنا ذلك استخدام بروميد methylthiazolyldiphenyl - tetrazolium (MTT) لفحص للسمية البوليمر في نوع من الخلايا الجديدة. نلاحظ بقاء يعادل HDFs بعد تنبيغ الفيروسية باستخدام البوليمر complexation أو جرعة قياسية من polybrene (PB ، 6 ميكروغرام / مل) ، مشيرا إلى الحد الأدنى من السمية الحادة. في هذا البروتوكول ، ونحن تصف استخدام الفيروسة البطيئة لecotropic overexpression من الجينات المسرطنة في الخلايا البشرية ، والحد من مخاطر السلامة البيولوجية وزيادة معدل تنبيغ. نظهر أيضا استخدام complexation البوليمر لتعزيز تنبيغ مع تجنب تشكيل الهباء الطرد المركزي من الجسيمات الفيروسية.

Watch this Scientific Journal Video about Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety at JoVE.com

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Lentiviruses هي أداة بحث قيما لاستكشاف وظائف الجينات ، إلا أن الباحثين قد ترغب في تجنب إنتاج ترميز الفيروسة البطيئة شمولي التوجه المسرطنة المعروفة أو المشتبه بهم. كبديل ، نقدم أكثر أمانا لاستخدام بروتوكول الفيروسة البطيئة ecotropic على الخلايا البشرية المعدلة للتعبير عن mSlc7a1 مستقبلات ecotropic.

تنبيغ من خلايا الإنسان مع البوليمر المعقد Ecotropic الفيروسة البطيئة للسلامة الأحيائية المحسن

Stem and tumor cell biology studies often require viral transduction of human cells with known or suspected oncogenes, raising major safety issues for ...

transduction-human-cells-with-polymer-complexed-ecotropic-lentivirus

Research

JoVE Journal

Biology

15.0K Views.  University of California, Davis. Lentiviruses هي أداة بحث قيما لاستكشاف وظائف الجينات ، إلا أن الباحثين قد ترغب في تجنب إنتاج ترميز الفيروسة البطيئة شمولي التوجه المسرطنة المعروفة أو المشتبه بهم. كبديل ، نقدم أكثر أمانا لاستخدام بروتوكول الفيروسة البطيئة ecotropic على الخلايا البشرية المعدلة للتعبير عن...

Video: Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Detection of Protein Ubiquitination

Ubiquitination, the covalent attachment of the polypeptide ubiquitin to target proteins, is a key posttranslational modification carried out by a set of three enzymes. They include ubiquitin-activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin ligase E3. Unlike to E1 and E2, E3 ubiquitin ligases display substrate specificity. On the other hand, numerous deubiquitylating enzymes have roles in processing polyubiquitinated proteins. Ubiquitination can result in change of protein stability, cellular localization, and biological activity. Mutations of genes involved in the ubiquitination/deubiquitination pathway or altered ubiquitin system function are associated with many different human diseases such as various types of cancer, neurodegeneration, and metabolic disorders. The detection of altered or normal ubiquitination of target proteins may provide a better understanding on the pathogenesis of these diseases. &nbsp;Here, we describe protocols to detect protein ubiquitination in cultured cells in vivo and test tubes in vitro. These protocols are also useful to detect other ubiquitin-like small molecule modification such as sumolyation and neddylation.

Ubiquitination is a key posttranslational modification carried out by a set of three enzymes. Mutations of genes involved in this modification are associated with many different human diseases. Here, we describe protocols to detect protein ubiquitination in cultured cells in vivo and test tubes in vitro.

اكتشاف بروتين Ubiquitination

Ubiquitination, the covalent attachment of the polypeptide ubiquitin to target proteins, is a key posttranslational modification carried out by a set of ...

Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System

Using a defined set of transcription factors and cell culture conditions, Yamanaka and colleagues demonstrated that retrovirus-mediated delivery and expression of Oct4, Sox2, c-Myc, and Klf4 is capable of inducing pluripotency in mouse fibroblasts.1 Subsequent reports have demonstrated the utility of the doxycycline (DOX) inducible lentiviral delivery system for the generation of both primary and secondary iPS cells from a variety of other adult mouse somatic cell types.2,3
Induced pluripotent stem (iPS) cells are similar to embryonic stem (ES) cells in morphology, proliferation and ability to induce teratoma formation. Both types of cell can be used as the pluripotent starting material for the generation of differentiated cells or tissues in regenerative medicine.4-6 iPS cells also have a distinct advantage over ES cells as they exhibit key properties of ES cells without the ethical dilemma of embryo destruction.
Here we demonstrate the protocol for reprogramming mouse embryonic fibroblast (MEF) cells with the Stemgent DOX Inducible Mouse TF Lentivirus Set. We also demonstrate that the Stemgent DOX Inducible Mouse TF Lentivirus Set is capable of expressing each of the four transcription factors upon transduction into MEFs thereby inducing a pluripotent stem cell state that displays the pluripotency markers characteristic of ES cells.

The Stemgent Dox Inducible Mouse TF Lentivirus Set can reprogram mouse embryonic fibroblasts (MEFs) to induced pluripotent stem (iPS) cells. Here we demonstrate the protocol for DOX-inducible expression of mouse reprogramming transcription factors Oct4, Sox2, Klf4 and c-Myc to generate iPS colonies that express common mES pluripotency markers.

جيل من الخلايا الجذعية المحفزة المستحثة عن طريق إعادة برمجة الخلايا الليفية الفأر الجنينية مع عامل النسخ أربعة ، والدوكسيسيكلين محرض Lentiviral نظام تنبيغ

Using a defined set of transcription factors and cell culture conditions, Yamanaka and colleagues demonstrated that retrovirus-mediated delivery and ...

Lentivirus Production

RNA interference (RNAi) is a system of gene silencing in living cells. In RNAi, genes homologous in sequence to short interfering RNAs (siRNA) are silenced at the post-transcriptional state. Short hairpin RNAs, precursors to siRNA, can be expressed using lentivirus, allowing for RNAi in a variety of cell types. Lentiviruses, such as the Human Immunodeficiency Virus, are capable to infecting both dividing and non-dividing cells. We will describe a procedure which to package lentiviruses. Packaging refers to the preparation of competent virus from DNA vectors. Lentiviral vector production systems are based on a 'split' system, where the natural viral genome has been split into individual helper plasmid constructs. This splitting of the different viral elements into four separate vectors diminishes the risk of creating a replication-capable virus by adventitious recombination of the lentiviral genome. Here, a vector containing the shRNA of interest and three packaging vectors (p-VSVG, pRSV, pMDL) are transiently transfected into human 293 cells. After at least a 48-hour incubation period, the virus containing supernatant is harvested and concentrated. Finally, virus titer is determined by reporter (fluorescent) expression with a flow cytometer.

To make lentiviruses, DNA vectors are transfected into human 293 cells. After harvest and concentrating the supernatant, virus titer is determined by fluorescence expression with a flow cytometer.

الفيروسة البطيئة الإنتاج

RNA interference (RNAi) is a system of gene silencing in living cells. In RNAi, genes homologous in sequence to short interfering RNAs (siRNA) are ...

Generation of Induced Pluripotent Stem Cells by Reprogramming Human Fibroblasts with the Stemgent Human TF Lentivirus Set

In 2006, Yamanaka and colleagues first demonstrated that retrovirus-mediated delivery and expression of Oct4, Sox2, c-Myc and Klf4 is capable of inducing the pluripotent state in mouse fibroblasts.1 The same group also reported the successful reprogramming of human somatic cells into induced pluripotent stem (iPS) cells using human versions of the same transcription factors delivered by retroviral vectors.2 Additionally, James Thomson et al. reported that the lentivirus-mediated co-expression of another set of factors (Oct4, Sox2, Nanog and Lin28) was capable of reprogramming human somatic cells into iPS cells.3
iPS cells are similar to ES cells in morphology, proliferation and the ability to differentiate into all tissue types of the body. Human iPS cells have a distinct advantage over ES cells as they exhibit key properties of ES cells without the ethical dilemma of embryo destruction. The generation of patient-specific iPS cells circumvents an important roadblock to personalized regenerative medicine therapies by eliminating the potential for immune rejection of non-autologous transplanted cells.
Here we demonstrate the protocol for reprogramming human fibroblast cells using the Stemgent Human TF Lentivirus Set. We also show that cells reprogrammed with this set begin to show iPS morphology four days post-transduction. Using the Stemolecule Y27632, we selected for iPS cells and observed correct morphology after three sequential rounds of colony picking and passaging. We also demonstrate that after reprogramming cells displayed the pluripotency marker AP, surface markers TRA-1-81, TRA-1-60, SSEA-4, and SSEA-3, and nuclear markers Oct4, Sox2 and Nanog.

We demonstrate the protocol for the generation of induced pluripotent stem cells from human somatic cells using lentivirus-mediated delivery of the human factors Oct4, Sox2, Nanog, and Lin28. Pluripotency was confirmed by morphology and the presence of embryonic stem (ES) cell-specific markers.

تعيين جيل من الخلايا الجذعية المحفزة المستحثة عن طريق إعادة برمجة الخلايا الليفية الإنسان مع الإنسان الفيروسة البطيئة TF Stemgent

In 2006, Yamanaka and colleagues first demonstrated that retrovirus-mediated delivery and expression of Oct4, Sox2, c-Myc and Klf4 is capable of inducing ...

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors

Oligodendrocytes are the myelinating cells of the central nervous system. For regenerative cell therapy in demyelinating diseases, there is significant interest in deriving a pure population of lineage-committed oligodendrocyte precursor cells (OPCs) for transplantation. OPCs are characterized by the activity of the transcription factor Olig2 and surface expression of a proteoglycan NG2. Using the GFP-Olig2 (G-Olig2) mouse embryonic stem cell (mESC) reporter line, we optimized conditions for the differentiation of mESCs into GFP+Olig2+NG2+ OPCs. In our protocol, we first describe the generation of embryoid bodies (EBs) from mESCs. Second, we describe treatment of mESC-derived EBs with small molecules: (1) retinoic acid (RA) and (2) a sonic hedgehog (Shh) agonist purmorphamine (Pur) under defined culture conditions to direct EB differentiation into the oligodendroglial lineage. By this approach, OPCs can be obtained with high efficiency (&gt;80%) in a time period of 30 days. Cells derived from mESCs in this protocol are phenotypically similar to OPCs derived from primary tissue culture. The mESC-derived OPCs do not show the spiking property described for a subpopulation of brain OPCs in situ. To study this electrophysiological property, we describe the generation of spiking mESC-derived OPCs by ectopically expressing NaV1.2 subunit. The spiking and nonspiking cells obtained from this protocol will help advance functional studies on the two subpopulations of OPCs.

We describe a small molecule-based protocol for differentiation of mouse embryonic stem cells into oligodendrocyte precursor cells (OPCs). This protocol generates Olig2+NG2+ OPCs with high efficiency by 30 days of differentiation. We also describe a method to generate "spiking" OPCs that can fire action potentials.

تمايز الخلايا الجذعية الجنينية في السلائف Oligodendrocyte

Oligodendrocytes are the myelinating cells of the central nervous system. For regenerative cell therapy in demyelinating diseases, there is significant ...

Proteomic Sample Preparation from Formalin Fixed and Paraffin Embedded Tissue

Preserved clinical material is a unique source for proteomic investigation of human disorders. Here we describe an optimized protocol allowing large scale quantitative analysis of formalin fixed and paraffin embedded (FFPE) tissue. The procedure comprises four distinct steps. The first one is the preparation of sections from the FFPE material and microdissection of cells of interest. In the second step the isolated cells are lysed and processed using 'filter aided sample preparation' (FASP) technique. In this step, proteins are depleted from reagents used for the sample lysis and are digested in two-steps using endoproteinase LysC and trypsin. 
After each digestion, the peptides are collected in separate fractions and their content is determined using a highly sensitive fluorescence measurement. Finally, the peptides are fractionated on 'pipette-tip' microcolumns. The LysC-peptides are separated into 4 fractions whereas the tryptic peptides are separated into 2 fractions. In this way prepared samples allow analysis of proteomes from minute amounts of material to a depth of 10,000 proteins. Thus, the described workflow is a powerful technique for studying diseases in a system-wide-fashion as well as for identification of potential biomarkers and drug targets.

Archival formalin fixed and paraffin embedded (FFPE) clinical samples are valuable material for investigation of diseases. Here we demonstrate a sample preparation workflow allowing in-depth proteomic analysis of microdissected FFPE tissue.

إعداد نموذج البروتين من الفورمالين الثابتة والبارافين جزءا لا يتجزأ من نسيج

Preserved clinical material is a unique source for proteomic investigation of human disorders. Here we describe an optimized protocol allowing large scale ...

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus

A few years ago, the establishment of human induced pluripotent stem cells (iPSCs) ushered in a new era in biomedicine. Potential uses of human iPSCs include modeling pathogenesis of human genetic diseases, autologous cell therapy after gene correction, and personalized drug screening by providing a source of patient-specific and symptom relevant cells. However, there are several hurdles to overcome, such as eliminating the remaining reprogramming factor transgene expression after human iPSCs production. More importantly, residual transgene expression in undifferentiated human iPSCs could hamper proper differentiations and misguide the interpretation of disease-relevant in vitro phenotypes. With this reason, integration-free and/or transgene-free human iPSCs have been developed using several methods, such as adenovirus, the piggyBac system, minicircle vector, episomal vectors, direct protein delivery and synthesized mRNA. However, efficiency of reprogramming using integration-free methods is quite low in most cases.
Here, we present a method to isolate human iPSCs by using Sendai-virus (RNA virus) based reprogramming system. This reprogramming method shows consistent results and high efficiency in cost-effective manner.

Here, we present our established method to reprogram human somatic cells into transgene-free human iPSCs with Sendai virus, which shows consistent outcome and enhanced efficiency.

كفاءة الجيل المستحثة الإنسان افرة القوة الخلايا الجذعية من الخلايا الجسدية البشرية مع سينداي الفيروسات

A few years ago, the establishment of human induced pluripotent stem cells (iPSCs) ushered in a new era in biomedicine. Potential uses of human iPSCs ...

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

One major limitation with current human embryonic stem cell (ESC) differentiation protocols is the generation of heterogeneous cell populations.&#160;These cultures contain the cells of interest, but are also contaminated with undifferentiated ESCs, non-neural derivatives and other neuronal subtypes.&#160; This limits their use in in vitro and in vivo applications, such as in vitro modeling for drug discovery or cell replacement therapy. To help overcome this, reporter cell lines, which offer a means to visualize, track and isolate cells of interest, can be engineered.&#160;However, to achieve this in human embryonic stem cells via conventional homologous recombination is extremely inefficient.&#160;This protocol describes targeting of the Pituitary homeobox 3 (PITX3) locus in human embryonic stem cells using custom designed zinc-finger nucleases, which introduce site-specific double-strand DNA breaks, together with a PITX3-EGFP-specific DNA donor vector. Following the generation of the PITX3 reporter cell line, it can then be differentiated using published protocols for use in studies such as in vitro Parkinson&#8217;s disease modeling or cell replacement therapy.

Reporter cell lines offer a means to visualize, track and isolate cells of interest from heterogeneous populations.&#160;However, gene-targeting using conventional homologous recombination in human embryonic stem cells is extremely inefficient. Herein, we describe targeting CNS midbrain specific transcription factor PITX3 locus with EGFP using zinc-finger nuclease enhanced homologous recombination.

الزنك الاصبع نوكلياز المحسن استهداف الجينات في الخلايا الجذعية الجنينية البشرية

One major limitation with current human embryonic stem cell (ESC) differentiation protocols is the generation of heterogeneous cell ...

Fluorescence Imaging with One-nanometer Accuracy (FIONA)

Fluorescence imaging with one-nanometer accuracy (FIONA) is a simple but useful technique for localizing single fluorophores with nanometer precision in the x-y plane. Here a summary of the FIONA technique is reported and examples of research that have been performed using FIONA are briefly described. First, how to set up the required equipment for FIONA experiments, i.e., a total internal reflection fluorescence microscopy (TIRFM), with details on aligning the optics, is described. Then how to carry out a simple FIONA experiment on localizing immobilized Cy3-DNA single molecules using appropriate protocols, followed by the use of FIONA to measure the 36 nm step size of a single truncated myosin Va motor labeled with a quantum dot, is illustrated. Lastly, recent effort to extend the application of FIONA to thick samples is reported. It is shown that, using a water immersion objective and quantum dots soaked deep in sol-gels and rabbit eye corneas (&#62;200 &#181;m), localization precision of 2-3 nm can be achieved.

Fluorescence Imaging with One-nanometer Accuracy FIONA

Single fluorophores can be localized with nanometer precision using FIONA. Here a summary of the FIONA technique is reported, and how to carry out FIONA experiments is described.

التصوير مضان مع نانومتر دقة واحدة (FIONA)

Fluorescence imaging with one-nanometer accuracy (FIONA) is a simple but useful technique for localizing single fluorophores with nanometer precision in ...

Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells

In vitro culture of primary human bronchial epithelial (HBE) cells using air-liquid interface conditions provides a useful model to study the processes of airway cell differentiation and function. In the past few years, the use of lentiviral vectors for transgene delivery became common practice. While there are reports of transduction of fully differentiated airway epithelial cells with certain non-HIV pseudo-typed lentiviruses, the overall transduction efficiency is usually less than 15%. The protocol presented here provides a reliable and efficient method to produce lentiviruses and to transduce primary human bronchial epithelial cells. Using undifferentiated bronchial epithelial cells, transduction in bronchial epithelial growth media, while the cells attach, with a multiplicity of infection factor of 4 provides efficiencies close to 100%. This protocol describes, step-by-step, the preparation and concentration of high-titer lentiviral vectors and the transduction process. It discusses the experiments that determined the optimal culture conditions to achieve highly efficient transductions of primary human bronchial epithelial cells.

Primary human bronchial epithelial cells are difficult to transduce. This protocol describes the production of lentiviruses and their concentration as well as the optimal culture conditions necessary to achieve highly efficient transductions in these cells throughout differentiation to a pseudostratified epithelium.

الأمثل الفيروسة البطيئة إنتاج وزراعة الخلايا الشروط الضرورية لبنجاح خلايا تنبيغ الإنسان الشعبي الأساسي طلائي

In vitro culture of primary human bronchial epithelial (HBE) cells using air-liquid interface conditions provides a useful model to study the processes of ...